Concepedia

Bing Zhao

BZ

Statistics

Publications

9

Citations

350

H-Index

9

Active since

2015

Affiliations

Nanjing University of Chinese Medicine(Current)

Zhengzhou University

St. John's University

Soochow University

Zhejiang Cancer Hospital

Bing Zhao is an author at Nanjing University of Chinese Medicine specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2015–2024

9

Publications

9

Formononetin ameliorates oxaliplatin-induced peripheral neuropathy via the KEAP1-NRF2-GSTP1 axis

Yuan Fang, Juan Ye, Bing Zhao et al. · Redox Biology · 2020 · 77 citations · Full text

, , +16

Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety as Orally Bioavailable Reversal Agents against P-Glycoprotein-Mediated Mutidrug Resistance

Bo Wang, Liying Ma, Jing‐Quan Wang et al. · Journal of Medicinal Chemistry · 2018 · 70 citations · Full text

, , +16

Blocking Ubiquitin‐Specific Protease 7 Induces Ferroptosis in Gastric Cancer via Targeting Stearoyl‐CoA Desaturase

Xiaoqing Guan, Yichao Wang, Wen-Kai Yu et al. · Advanced Science · 2024 · 56 citations · Full text

Exploration of 1,2,3-triazole-pyrimidine hybrids as potent reversal agents against ABCB1-mediated multidrug resistance

Bo Wang, Bing Zhao, Zhe‐Sheng Chen et al. · European Journal of Medicinal Chemistry · 2017 · 50 citations

, , +11

Dual inhibition of MYC and SLC39A10 by a novel natural product STAT3 inhibitor derived from Chaetomium globosum suppresses tumor growth and metastasis in gastric cancer

Xiaoqing Guan, Jing Yang, Weiyi Wang et al. · Pharmacological Research · 2023 · 30 citations · Full text

1–5 of 9